International Clinical Trial: SPF of Baypure Gel Sunscreen B6042

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109121) titled 'SPF of Baypure Gel Sunscreen B6042' on April 22.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Baypure Lifestyle Pvt Ltd

Intervention: Intervention1: Test Product: Gel Sunscreen B6042: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour Control Intervention1: Reference Sunscreen: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour

Recruitment Status: Not Recruiting

Phase: Post...